Archive for January, 2010

Exposed! Outmanoeuvring Mechanism of Brain Tumors to Drug Treatments
Exposed! Outmanoeuvring Mechanism of Brain Tumors to Drug Treatments
Findings of a latest study have revealed one method that gliomas –a lethal form of brain tumor could dodge medicines directed at hindering a crucial cell signalling protein, EGFR (epidermal growth factor receptor) which is fundamental for tumor development. In an interrelated discovery, they additionally established that a predominant EGFR mutation is significant not just in initiating the tumor, but for its continual augmentation or even for their continuance. These findings offer both novel percipiency into behavioural pattern of gliomas alongside prospective novel medicine targets and therapy approaches. The outcomes indicate that EGFR being expressed is crucial to tumor growth and researchers have shown for the foremost instance that there are means which tumors employ for circumventing  [...]

January 29th, 2010 | Brain Cancer
Promising Blood test For Pancreatic Cancer Detection
Promising Blood test For Pancreatic Cancer Detection
Scientists state that they have been successful in developing a blood test which could detect pancreatic cancer early on in its more treatable stages. The test employs an antibody that functions as a heat-detecting projectile that homes in and attaches to cells which bear PAM4 protein which is found vastly in pancreatic cancer cases. The researchers stated that this protein is pancreatic cancer-specific and is atypically present in healthy tissues or in other types of cancers. Vitally, PAM4 is hardly ever identified in pancreatitis – an ailment wherein there is pancreatic inflammation which is originally mostly tricky in distinguishing from pancreatic cancer. The antibody additionally shows potential for treatment of cancer by functioning as a carter for radiation or medicines which could  [...]

January 27th, 2010 | Pancreatic Cancer
Promising Blood Test for Lung Cancer Diagnosis Under revision
Promising Blood Test for Lung Cancer Diagnosis Under revision
Scientists have been perfecting a blood analysis test to assist in diagnosing lung cancer that shows immense potential. In case the test could be streamlined, it could aid in sparing patients the requirement of undergoing invasive diagnosis methods like biopsy when lung cancer has been doubted. Presently, twenty to twenty-five percent of the surgical procedures performed in case of dubious lung cancer emerge out to be non-malignant identification. The American Cancer Society has approximated close to 1,59,000 lung cancer-related fatalities and above two lakhs newly surfaced lung cancer cases that are all grim facts about lung cancer. Scientists explained that nearly 1 among five hundred X-rays done of the chest region reveals a lung nodule having an undetermined consequence. In case this happens,  [...]

January 21st, 2010 | Lung Cancer
Inspiring Celeb Toughies who Survived Cancer
Inspiring Celeb Toughies who Survived Cancer
Undoubtedly cancer is a blot on humankind; annually sucking out the lives of innumerable individuals globally. Unprejudiced, cancer strikes all races, ages, affluence or penniless. With similar vengeance cancer also afflicts our famous celebs consuming lives of several of them. However, several famed personalities are mighty fighters that have survived the tribulation and jumped back stronger than ever before. The sole real difference with luminaries that have resiliently found cancer and subsisted is that they are back in the public glare and are a lucid motivation for all enduring cancer to never stop being hopeful and despite hardships keep carrying on, fighting back and optimistically triumph over the combat against the varied ugly faces of cancer. Here are merely some of the numerous celeb  [...]

January 19th, 2010 | News
Breast Cancer Oncotype DX Testing – Positively Impacting Chemotherapy Treatment Choices
Breast Cancer Oncotype DX Testing – Positively Impacting Chemotherapy Treatment Choices
A multi-gene test that forecasts if preliminary staging breast cancer patients would be benefitted due to chemotherapy is majorly impacting treatment verdicts taken by both the patient and physicians comparably. The multi-gene test known as Oncotype DX manufactured by Genomic Health Industries lead to doctors changing their treatment suggestions in about thirty-two percent of the cases whereas twenty-seven percent of the patients modified their treatment choices. In majority of these cases, the amendment in decision was observed from both the doctors as well as the patient’s end to steer clear from undergoing chemotherapy. The Oncotype DX multi-gene test evaluates twenty-one genes from a neoplasm sample for ascertaining how progressive the neoplasms were. An analysis score lying from zero  [...]

January 14th, 2010 | Breast Cancer
A Primer on Ataxia-Telangiectasia
A Primer on Ataxia-Telangiectasia
Ataxia-Telangiectasia or (A-T) is a heritable condition typified by advancing neurologic issues leading to walking difficulties. Ataxia telangiectasia symptoms generally start developing during infancy. Infants having A-T would start to stagger and seem to exhibit unsteadiness (ataxia) brusquely after having learnt to walk. Majority of the individuals having A-T would in due course of time require the assistance of a wheelchair. Those with A-T have normal I.Qs , however over periods of time they would begin developing slurry verbal communication and have problems when doing several chores including writing. Ataxia Telangiectasia Symptoms As the person ages reddish spots known as telangiectasias emerge on the skin and eyes due to dilatation of the fine blood vessels (capillaries). Individuals  [...]

January 11th, 2010 | Ataxia-Telangiectasia
Role Of ProstaScint And Radionuclide Bone Scan In Prostate Cancer Diagnosis
Role Of ProstaScint And Radionuclide Bone Scan In Prostate Cancer Diagnosis
Prostate Cancer that has metastasized to the remote locations mostly reaches the bones, but would continue to be known as prostate and not bone cancer. A Radionuclide bone scan comes into the picture to assist in showing if the cancer has inflicted the bones. For performing a radionuclide bone scan a miniscule quantity of radioactive matter is administered as an intravenous shot after which the material would settle in the bone tissue that has faced damage all through the skeletal system in the span of a few hours. The person is then requested to lay flat on a table for nearly thirty minutes during which time a specialised camera identifies the radioactive substance and produces an image of the skeletal structure. Regions where the bone tissue have been damaged due to the cancer presence are  [...]

January 4th, 2010 | Prostate Cancer
Gestational Trophoblastic Tumors
Gestational Trophoblastic Tumors
Gestational Trophoblastic tumours or GTTs generally originate in the womb that is diverse from womb cancers. Womb cancers grow from the cells that constitute the womb, while a gestational trophoblastic tumor develops from tissues which form the womb and are components of the usual foetal development during the gestational or pregnancy phase. Generally subsequent to fertilization of the egg by the sperm, novel cells start developing that lead to the formation of an embryo. With the continual growth of the embryo, the cells within it begin specialising with some of them forming the foetus and rest of them forming the placenta. The foremost cell layer which forms the placenta is known as the trophoblast. Those women having GTT have anomalous cell growth and development of the tissues forming the  [...]

January 1st, 2010 | Tumor